AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 8.462
NA - Nord America 5.367
EU - Europa 2.177
SA - Sud America 413
OC - Oceania 55
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.508
Nazione #
HK - Hong Kong 6.519
US - Stati Uniti d'America 5.284
SG - Singapore 748
CN - Cina 588
IT - Italia 395
RU - Federazione Russa 392
BR - Brasile 374
UA - Ucraina 339
DE - Germania 293
IE - Irlanda 217
TR - Turchia 179
VN - Vietnam 163
SE - Svezia 150
KR - Corea 132
EE - Estonia 107
GB - Regno Unito 98
FI - Finlandia 73
CA - Canada 53
IN - India 40
FR - Francia 32
AU - Australia 30
NZ - Nuova Zelanda 24
JP - Giappone 21
BD - Bangladesh 18
AR - Argentina 15
NL - Olanda 15
CZ - Repubblica Ceca 14
PL - Polonia 14
MX - Messico 12
ZA - Sudafrica 11
AT - Austria 10
ES - Italia 8
VE - Venezuela 8
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
IQ - Iraq 6
UZ - Uzbekistan 6
BE - Belgio 5
EU - Europa 5
KE - Kenya 5
CL - Cile 4
ID - Indonesia 4
JM - Giamaica 4
NP - Nepal 4
CH - Svizzera 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
EC - Ecuador 2
ET - Etiopia 2
IR - Iran 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
TJ - Tagikistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MR - Mauritania 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 16.508
Città #
Hong Kong 6.510
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Singapore 305
Dallas 272
Houston 248
Ashburn 226
Dublin 204
Woodbridge 201
Izmir 166
Dong Ket 136
Beijing 121
Nanjing 112
Moscow 109
Tallinn 107
Andover 104
Boardman 86
Salerno 69
Munich 65
Pellezzano 64
Düsseldorf 55
Norwalk 53
Dearborn 44
Shenyang 43
Nanchang 39
Los Angeles 38
Fairfield 34
Mestre 34
Naples 34
Hebei 29
São Paulo 29
Redwood City 26
Jiaxing 25
San Francisco 24
Changsha 19
Rome 18
Tianjin 18
Pune 17
Milan 16
New York 16
Nuremberg 16
Rio de Janeiro 16
San Diego 16
Washington 16
Council Bluffs 15
The Dalles 15
Casoria 14
Montreal 13
Turku 13
Brooklyn 12
Auckland 11
Belo Horizonte 11
Boston 11
Chennai 11
Guangzhou 11
Ho Chi Minh City 11
Sydney 11
Columbus 10
London 10
West Jordan 10
Amsterdam 9
Atlanta 9
Hanoi 9
Santa Clara 9
Warsaw 9
Ankara 8
Stockholm 8
Brasília 7
Cambridge 7
Jinan 7
Santa Maria A Vico 7
Seattle 7
Wuhan 7
Carapicuíba 6
Chicago 6
Dhaka 6
Dormagen 6
Fuzhou 6
Guarulhos 6
Hefei 6
Napoli 6
Ribeirão Preto 6
Tokyo 6
Anápolis 5
Brussels 5
Curitiba 5
Fukushima 5
Hangzhou 5
Johannesburg 5
Kunming 5
Manchester 5
Melbourne 5
Nairobi 5
Paris 5
Sant'arpino 5
Tashkent 5
Adelaide 4
Totale 13.230
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 841
Sex Differences in Parkinson’s Disease: From Bench to Bedside 488
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 453
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 444
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 436
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 410
Gender differences in microRNA expression in levodopa-naive PD patients 392
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 388
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 353
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 275
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 242
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 225
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 219
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 218
The most effective way to obtain long-term memory is to increase first presentation duration of single words 209
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 193
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 187
Classifying Different Stages of Parkinson’s Disease Through Random Forests 175
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 174
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 162
Metabolomics in Parkinson's disease 153
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 150
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 146
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 144
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 144
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 141
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 141
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 139
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 124
Increased bilirubin levels in de novo Parkinson's disease 118
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 116
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 111
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 110
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 109
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 108
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 107
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 106
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 106
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 106
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 105
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 104
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 103
Freezing of gait and executive functions in patients with Parkinson’s disease 102
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
Machine learning can predict mild cognitive impairment in Parkinson's disease 96
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 96
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 95
Abnormal eating behaviors in progressive supranuclear palsy. 94
Bisphenol A glucuronidation in patients with Parkinson's disease 92
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 92
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 91
Quitting smoking: An early non-motor feature of Parkinson's disease? 90
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 90
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 90
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 89
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 88
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 88
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 86
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 86
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 85
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 85
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 84
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 83
Uric acid relates to dopamine transporter availability in Parkinson's disease. 82
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 82
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 82
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 82
Parkinson’s disease and the spectrum of Lewy body disease 80
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 79
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 78
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 78
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 75
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 74
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 73
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 73
Resting brain networks in patients with Parkinson's disease and freezing of gait 72
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 72
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 72
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 71
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 71
Caratteristiche Cliniche 71
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 70
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 70
Cognitive contributions to gait and falls: Evidence and implications 70
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 69
The "eye of the tiger" sign in pure akinesia with gait freezing. 68
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 67
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 67
Freezing of gait and executive functions in patients with Parkinson's disease. 66
Hemi-restless legs syndrome induced by clebopride 66
“Response to Apomorphine in early Parkinson’s disease”. 66
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease 64
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 64
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients 63
Future thinking in Parkinson's disease: An executive function? 63
Clinical and neurological abnormalities in adult celiac disease. 63
Totale 13.897
Categoria #
all - tutte 53.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021664 0 0 62 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/20267.242 1.587 4.538 1.117 0 0 0 0 0 0 0 0 0
Totale 16.903